NICE gives final draft guidance on two key cancer drugs
October 12, 2017Sales and Marketing Bayer, CDF, Cancer, Cancer Drugs Fund, Erivedge, NICE, Roche, Stivarga
NICE has announced it has published its final draft guidance for two cancer treatments, covering Bayer’s Stivarga (regorafenib) in the …
MSD gives up on cholesterol drug, despite positive results
October 12, 2017Medical Communications, Sales and Marketing MSD, Merck, biotech, cholesterol, drugs, pharma, pharmaceutical
MSD, known as Merck in North America, has revealed that it will not pursue a regulatory filing for its cholesterol …
Sanofi set for €170 million expansion of vaccine facility
October 12, 2017Manufacturing and Production Sanofi, Sanofi Pasteur, biotech, drugs, influenza, pharma, pharmaceutical
Sanofi has announced that it plans to expand its vaccine manufacturing facility in Val de Reuil, France, with an injection …
Childhood obesity increased 10-fold over last four decades
October 11, 2017Research and Development biotech, drugs, obese, obesity, pharma, pharmaceutical
An analysis of childhood and teenage obesity levels around the world have revealed that the numbers who are considered dangerously …
Lupin scoops up women’s health specialist Symbiomix for $150 million
October 11, 2017Research and Development, Sales and Marketing India, Lupin, Lupin Pharmaceuticals, Symbiomix, US, acquisition, pharma
The US arm of Mumbai’s Lupin Pharmaceuticals has announced that it is has acquired US-based gynaecologic treatment specialist Symbiomix Therapeutics …
Moffitt scientists discover new applications for Novartis’s Zykadia
October 11, 2017Research and Development Cancer, Moffitt, NSCLC, ceritinib, lung cancer, zykadia
Through the use of molecular screening, functional proteomics and computer-based modelling, researchers from the Moffitt Cancer Center have been working …
Mylan and Biocon Neulasta biosimilar knocked back by FDA
October 11, 2017Research and Development, Sales and Marketing Amgen, Biocon, Mylan, Neulasta, biotech, drugs, pharma, pharmaceutical
Mylan and Biocon’s biosimilar version of Amgen’s blockbuster, Neulasta (pegfilgrastim), will have to wait a bit longer before getting the …
Allergan settles gender discrimination case for $4m
October 11, 2017Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical
It could have been much worse for Allergan, after it agreed to pay $4 million to resolve a lawsuit alleging …
NHS Scotland appoints new Chief Scientist
October 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Scotland, biotech, drugs, pharma, pharmaceutical
NHS Scotland has revealed the appointment of Professor David Crossman as its new Chief Scientist, after advertising externally to fill …
Use of antacids found to promote liver disease
October 10, 2017Manufacturing and Production, Research and Development biotech, drugs, liver disease, pharma, pharmaceutical
A study emerging from the University of California, San Diego, has revealed a correlation between the use of common acid …
Scottish government reveals extra funding for mental health
October 10, 2017Manufacturing and Production, Medical Communications Scotland, biotech, drugs, mental health, pharma, pharmaceutical
The Scottish government, on Mental Health Day, has revealed that it will boost spending on mental health services by £500,000. …
California signs into law transparency over drug pricing
October 10, 2017Manufacturing and Production, Sales and Marketing Drug pricing, biotech, california, drugs, pharma, pharmaceutical
In a move that is guaranteed to result in further lawsuits and acrimony, California has signed into law a requirement …
GSK ranked at bottom of ‘good governance’ report
October 10, 2017Manufacturing and Production, Medical Communications Diageo, GSK, biotech, drugs, pharma, pharmaceutical
A new report emerging from the Institute of Directors placed UK pharma giant, GSK, in last place out of 103 …
J&J exits insulin pump business, rival looks to scoop patients
October 10, 2017Manufacturing and Production Johnson & Johnson, biotech, diabetes, drugs, pharma, pharmaceutical
Johnson & Johnson’s Animas Corporation will cease business and close operations after the pharma giant could not find a buyer …
Harnessing the power of the immune system
October 9, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, immunotherapy, pharma, pharmaceuticals
Dr Áine McCarthy, Senior Science Information Officer at Cancer Research UK, discusses the latest efforts to further understand the immunotherapies …
Roche’s 99% accurate Zika test receives FDA approval
October 9, 2017Sales and Marketing Roche, Zika, biotech, drugs, pharma, pharmaceutical
Roche has revealed that the FDA has given approval to its cobas Zika test to determine whether a blood sample …
AstraZeneca’s Tagrisso secures Breakthrough Therapy Designation in first-line NSCLC
October 9, 2017Sales and Marketing AstraZeneca, Cancer, NSCLC, immunotherapy, lung cancer
AstraZeneca has announced that its targeted therapy, Tagrisso (osimertinib), has been awarded Breakthrough Therapy Designation by the FDA for the …
Trump sweeps away birth control coverage
October 9, 2017Medical Communications, Sales and Marketing President trump, Trump, biotech, birth control, drugs, pharma, pharmaceutical
Part of Obama’s Affordable Care Act included the provision that employer-provided health insurance must cover birth control, President Trump has …
China to accelerate drug approvals with overseas trial data
October 9, 2017Research and Development, Sales and Marketing China, drug approvals, pharma, pharmaceuticals
In a bid to speed up access to medicines for patients, China has revealed it intends to incorporate data from …
Battery implant approved to treat sleep apnea
October 9, 2017Sales and Marketing FDA, biotech, drugs, pharma, pharmaceutical
The FDA has announced the approval of a new form of treatment for central sleep apnea, in the form of …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
